Estrogen inhibits interleukin-18 mRNA expression in the mouse uterus

Yousuke Murakami, Mariko Otsuki, Kenji Kusumoto, Sakae Takeuchi, Sumio Takahashi

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Interleukin-18 (IL-18) is a proinflammatory cytokine expressed in female reproductive organs in humans, rats and mice. The physiological roles of uterine IL-18 and the regulatory mechanisms of IL-18 gene expression are unclear. The present study aimed to clarify the effects of estradiol-17β(E2) and progesterone (P4) on IL-18 mRNA expression in the mouse uterus. Distribution and expression levels of IL-18 mRNA were studied using an RNase protection assay. Expression of IL-18 mRNA was observed in all organs studied, including testes, ovaries and uteri. The uterine IL-18 mRNA level of estrous mice was higher than that of diestrous mice. E2 treatment (1, 5, 25 or 250 ng/ mouse) decreased uterine IL-18 mRNA levels in ovariectomized mice dose-dependently. E2 treatment acutely decreased IL-18 mRNA levels 3 h after injection, but these levels returned to the initial level after 48 h. P4 treatment (1 mg/mouse) decreased uterine IL-18 mRNA levels after 12 h, but levels returned to the initial level after 48 h. Both uterine IL-18 and IL-18Rα mRNAs were detected in cultured endometrial epithelial and stromal cells. These results suggest that uterine IL-18 expression is reduced by sex steroid hormones and that IL-18 acts on endometrial cells in a paracrine or autocrine manner.

Original languageEnglish
Pages (from-to)639-647
Number of pages9
JournalJournal of Reproduction and Development
Volume51
Issue number5
DOIs
Publication statusPublished - Oct 2005

Fingerprint

interleukin-18
Interleukin-18
uterus
estrogens
Uterus
Estrogens
Messenger RNA
mice
sex hormones
stromal cells
Gonadal Steroid Hormones
steroid hormones
Ribonucleases
Stromal Cells
cultured cells
Progesterone
estradiol
Testis
gonads

Keywords

  • Estrogen
  • Interleukin-18
  • Progestin
  • Uterus

ASJC Scopus subject areas

  • Animal Science and Zoology
  • Reproductive Medicine

Cite this

Estrogen inhibits interleukin-18 mRNA expression in the mouse uterus. / Murakami, Yousuke; Otsuki, Mariko; Kusumoto, Kenji; Takeuchi, Sakae; Takahashi, Sumio.

In: Journal of Reproduction and Development, Vol. 51, No. 5, 10.2005, p. 639-647.

Research output: Contribution to journalArticle

Murakami, Yousuke ; Otsuki, Mariko ; Kusumoto, Kenji ; Takeuchi, Sakae ; Takahashi, Sumio. / Estrogen inhibits interleukin-18 mRNA expression in the mouse uterus. In: Journal of Reproduction and Development. 2005 ; Vol. 51, No. 5. pp. 639-647.
@article{e8457c0fbcb64c17bbc30e3358e2de37,
title = "Estrogen inhibits interleukin-18 mRNA expression in the mouse uterus",
abstract = "Interleukin-18 (IL-18) is a proinflammatory cytokine expressed in female reproductive organs in humans, rats and mice. The physiological roles of uterine IL-18 and the regulatory mechanisms of IL-18 gene expression are unclear. The present study aimed to clarify the effects of estradiol-17β(E2) and progesterone (P4) on IL-18 mRNA expression in the mouse uterus. Distribution and expression levels of IL-18 mRNA were studied using an RNase protection assay. Expression of IL-18 mRNA was observed in all organs studied, including testes, ovaries and uteri. The uterine IL-18 mRNA level of estrous mice was higher than that of diestrous mice. E2 treatment (1, 5, 25 or 250 ng/ mouse) decreased uterine IL-18 mRNA levels in ovariectomized mice dose-dependently. E2 treatment acutely decreased IL-18 mRNA levels 3 h after injection, but these levels returned to the initial level after 48 h. P4 treatment (1 mg/mouse) decreased uterine IL-18 mRNA levels after 12 h, but levels returned to the initial level after 48 h. Both uterine IL-18 and IL-18Rα mRNAs were detected in cultured endometrial epithelial and stromal cells. These results suggest that uterine IL-18 expression is reduced by sex steroid hormones and that IL-18 acts on endometrial cells in a paracrine or autocrine manner.",
keywords = "Estrogen, Interleukin-18, Progestin, Uterus",
author = "Yousuke Murakami and Mariko Otsuki and Kenji Kusumoto and Sakae Takeuchi and Sumio Takahashi",
year = "2005",
month = "10",
doi = "10.1262/jrd.17029",
language = "English",
volume = "51",
pages = "639--647",
journal = "Journal of Reproduction and Development",
issn = "0916-8818",
publisher = "Japanese Society of Animal Reproduction (JSAR)",
number = "5",

}

TY - JOUR

T1 - Estrogen inhibits interleukin-18 mRNA expression in the mouse uterus

AU - Murakami, Yousuke

AU - Otsuki, Mariko

AU - Kusumoto, Kenji

AU - Takeuchi, Sakae

AU - Takahashi, Sumio

PY - 2005/10

Y1 - 2005/10

N2 - Interleukin-18 (IL-18) is a proinflammatory cytokine expressed in female reproductive organs in humans, rats and mice. The physiological roles of uterine IL-18 and the regulatory mechanisms of IL-18 gene expression are unclear. The present study aimed to clarify the effects of estradiol-17β(E2) and progesterone (P4) on IL-18 mRNA expression in the mouse uterus. Distribution and expression levels of IL-18 mRNA were studied using an RNase protection assay. Expression of IL-18 mRNA was observed in all organs studied, including testes, ovaries and uteri. The uterine IL-18 mRNA level of estrous mice was higher than that of diestrous mice. E2 treatment (1, 5, 25 or 250 ng/ mouse) decreased uterine IL-18 mRNA levels in ovariectomized mice dose-dependently. E2 treatment acutely decreased IL-18 mRNA levels 3 h after injection, but these levels returned to the initial level after 48 h. P4 treatment (1 mg/mouse) decreased uterine IL-18 mRNA levels after 12 h, but levels returned to the initial level after 48 h. Both uterine IL-18 and IL-18Rα mRNAs were detected in cultured endometrial epithelial and stromal cells. These results suggest that uterine IL-18 expression is reduced by sex steroid hormones and that IL-18 acts on endometrial cells in a paracrine or autocrine manner.

AB - Interleukin-18 (IL-18) is a proinflammatory cytokine expressed in female reproductive organs in humans, rats and mice. The physiological roles of uterine IL-18 and the regulatory mechanisms of IL-18 gene expression are unclear. The present study aimed to clarify the effects of estradiol-17β(E2) and progesterone (P4) on IL-18 mRNA expression in the mouse uterus. Distribution and expression levels of IL-18 mRNA were studied using an RNase protection assay. Expression of IL-18 mRNA was observed in all organs studied, including testes, ovaries and uteri. The uterine IL-18 mRNA level of estrous mice was higher than that of diestrous mice. E2 treatment (1, 5, 25 or 250 ng/ mouse) decreased uterine IL-18 mRNA levels in ovariectomized mice dose-dependently. E2 treatment acutely decreased IL-18 mRNA levels 3 h after injection, but these levels returned to the initial level after 48 h. P4 treatment (1 mg/mouse) decreased uterine IL-18 mRNA levels after 12 h, but levels returned to the initial level after 48 h. Both uterine IL-18 and IL-18Rα mRNAs were detected in cultured endometrial epithelial and stromal cells. These results suggest that uterine IL-18 expression is reduced by sex steroid hormones and that IL-18 acts on endometrial cells in a paracrine or autocrine manner.

KW - Estrogen

KW - Interleukin-18

KW - Progestin

KW - Uterus

UR - http://www.scopus.com/inward/record.url?scp=27744563034&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27744563034&partnerID=8YFLogxK

U2 - 10.1262/jrd.17029

DO - 10.1262/jrd.17029

M3 - Article

VL - 51

SP - 639

EP - 647

JO - Journal of Reproduction and Development

JF - Journal of Reproduction and Development

SN - 0916-8818

IS - 5

ER -